跳至主要内容
临床试验/NCT00140881
NCT00140881已完成4 期

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children

Organon and Co0 个研究点目标入组 220 人开始时间: 2000年6月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
220
主要终点
Composite unscheduled acute health care resource utilisation (specific for asthma; unscheduled visits, GP attendance, ED attendance and hospital admission).

研究概览

简要总结

A 53-week study to determine the effect of montelukast sodium when given to children (with infrequent episodic asthma) at the earliest symptoms of an acute episode of asthma.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
2 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Males or females between the ages of 2 and 14 who have infrequent episodic asthma.

排除标准

  • 未提供

结局指标

主要结局

Composite unscheduled acute health care resource utilisation (specific for asthma; unscheduled visits, GP attendance, ED attendance and hospital admission).

次要结局

  • Parent/caregiver QOL endpoints.
  • The safety and tolerability of montelukast when use as an episode modifier.
  • The duration and severity of the episode assessed by the parent/caregiver symptom score and the use of b-agonist and oral corticosteroid.

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

A Study to Determine the Effect of Montelukast... | 临床试验